BioPharma Credit (UK) Today
| BPCR Stock | 0.90 0.01 1.10% |
PerformanceModest
| Odds Of DistressLow
|
BioPharma Credit is selling for under 0.9 as of the 24th of June 2025; that is 1.1 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.9. BioPharma Credit has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 25th of May 2025 and ending today, the 24th of June 2025. Click here to learn more.
Business Domain Financial Services | Classification Financials |
BioPharma Credit is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 1.13 B outstanding shares. More on BioPharma Credit PLC
Moving together with BioPharma Stock
| 0.65 | NBB | Norman Broadbent Plc Split | PairCorr |
| 0.82 | 0HRR | CVR Energy | PairCorr |
| 0.73 | 0I9F | Digital Realty Trust | PairCorr |
Moving against BioPharma Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
BioPharma Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioPharma Credit's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioPharma Credit or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Banks (View all Themes) |
| Business Concentration | Asset Management & Custody Banks, Financial Services, Financials, Banks, Financials, Capital Markets, Financial Services, Financial Services (View all Sectors) |
BioPharma Credit PLC (BPCR) is traded on London Exchange in UK and employs 3 people. BioPharma Credit is listed under Asset Management & Custody Banks category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 101.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPharma Credit's market, we take the total number of its shares issued and multiply it by BioPharma Credit's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioPharma Credit PLC operates under Capital Markets sector and is part of Financials industry. The entity has 1.13 B outstanding shares.
BioPharma Credit generates positive cash flow from operations, but has no cash available
Check BioPharma Credit Probability Of Bankruptcy
Ownership AllocationBioPharma Credit holds a total of 1.13 Billion outstanding shares. 30% of BioPharma Credit PLC outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioPharma Ownership Details
BioPharma Credit PLC Risk Profiles
Although BioPharma Credit's alpha and beta are two of the key measurements used to evaluate BioPharma Credit's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.7477 | |||
| Semi Deviation | 1.03 | |||
| Standard Deviation | 1.22 | |||
| Variance | 1.5 |
BioPharma Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioPharma Credit without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Additional Tools for BioPharma Stock Analysis
When running BioPharma Credit's price analysis, check to measure BioPharma Credit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioPharma Credit is operating at the current time. Most of BioPharma Credit's value examination focuses on studying past and present price action to predict the probability of BioPharma Credit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioPharma Credit's price. Additionally, you may evaluate how the addition of BioPharma Credit to your portfolios can decrease your overall portfolio volatility.